Importance of different pathways of cellular cholesterol efflux

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 5, 2003, Pages 712-719

  Yancey, Patricia G ^b   Bortnick, Anna E ^b   Kellner Weibel, Ginny ^b   De la Llera Moya, Margarita ^b   Phillips, Michael C ^b   Rothblat, George H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

ATP binding cassette transporter AI; Cholesterol efflux; Reverse cholesterol transport; Scavenger receptor class BI

Indexed keywords

APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL MEMBRANE; CELL TRANSPORT; CHOLESTEROL TRANSPORT; DIFFUSION; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL;

ANTIGENS, CD36; APOLIPOPROTEINS; ARTERIOSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHOLESTEROL; CHOLESTEROL, HDL; DIFFUSION; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B;

EID: 0038705071     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000057572.97137.DD     Document Type: Article

References (85)

1. Badimon JJ, Fuster V, Badimon L. Role of high density lipoproteins in the regression of atherosclerosis. Circulation. 1992;86:86-94.
2. Barter PJ, Rye K-A. High density lipoproteins and coronary heart disease. Atherosclerosis. 1996;121:1-12.
3. Nofer J-R, Kehrel B, Fobker M, Levkau B, Assmann G, Von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 2002;161:1-16.
4. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, Wilson PWF. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res. 1994;35:871-882.
5. Glomset JA. The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-167.
6. McLean LR, Phillips MC. Mechanism of cholesterol and phosphatidylcholine exchange or transfer between unilamellar vesicles. Biochem. 1981;20:2893-2900.
7. Rothblat GH, Phillips MC. Mechanism of cholesterol efflux from cells: effects of acceptor structure and concentration. J Biol Chem. 1982;257:4775-4782.
8. Phillips MC, Johnson WJ, Rothblat GH. Mechanism and consequence of cellular cholesterol exchange and transfer. Biochim Biophys Acta. 1987;906:223-276.
9. Phillips MC, Gillotte KL, Haynes MP, Johnson WJ, Lund-Katz S, Rothblat GH. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. Atherosclerosis. 1998;137:S13-S17.
10. Lund-Katz S, Laboda HM, McLean LR, Phillips MC. Influence of molecular packing and phospholipid type on rates of cholesterol exchange. Biochemistry. 1988;27:3416-3423.
11. Johnson WJ, Mahlberg FH, Rothblat GH, Phillips MC. Cholesterol transport between cells and high density lipoproteins. Biochim Biophys Acta. 1991;1085:273-298.
12. Rothblat GH, de la Llera-Moya M, Atger V, Kellner-Weibel G, Williams DL, Phillips MC. Cell cholesterol, efflux: integration of old an new observations provides new insights. J Lipid Res. 1999;40:781-796.
13. Yancey PG, Rodrigueza WV, Kilsdonk EPC, Stoudt GW, Johnson WJ, Phillips MC, Rothblat GH. Cellular cholesterol efflux mediated by cyclodextrins: demonstration of kinetic pools and mechanism of efflux. J Biol Chem. 1996;271:16026-16034.
14. Zhao YY, Marcel Y. Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins. Biochem. 1996;35:7174-7180.
15. Rothblat GH, Bamberger M, Phillips MC. Reverse cholesterol transport. In: Albers J, Segrest J, eds. Methods in Enzymology. Vol 129. New York: Academic Press; 1986:628-644.
16. Ji Y, Jian B, Wang N, Sun Y, de la Llera Moya M, Phillips MC, Rothblat GH, Swaney JB, Tall AR. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem. 1997;272:20982-20985.
17. Jian B, de la Llera Moya M, Ji Y, Wang N, Phillips MC, Swaney JB, Tall AR, Rothblat GH. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem. 1998;273:5599-5606.
18. de la Llera-Moya M, Rothblat GH, Connelly MA. Kellner-Weibel G, Sakr SW, Phillips MC, Williams DL. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Res. 1999;40:575-580.
19. Kellner-Weibel G, de la Llera-Moya M, Connelly MA, Stoudt G, Christian AE, Haynes MP, Williams DL, Rothblat GH. Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry. 2000;39:221-229.
20. Yancey PG, de la Llera-Moya M, Swarnakar S, Monzo P, Klein SM, Connelly MA, Johnson WJ, Williams DL, Rothblat GH. HDL phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor-BI (SR-BI). J Biol Chem. 2000;275:36596-36604.
21. de la Llera-Moya M, Connelly MA, Drazul D, Klein SM, Favari E, Yancey PG, Williams DL, Rothblat GH. Scavenger receptor, class B, type I (SR-BI) affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J Lipid Res. 2001;42:1969-1978.
22. Thuahnai ST, Lund-Katz S, Williams DL, Phillips MC. Scavenger receptor class B, type-I-mediated uptake of various lipids into cells. J Biol Chem. 2001;276:43801-43808.
23. Krieger M. Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem. 1999;68:523-558.
24. Williams DL, Connelly MA, Temel RE, Swanakar S, Phillips MC, de la Llera-Moya M, Rothblat GH. Scavenger receptor BI and cholesterol trafficking. Curr Opin Lipidol. 1999;10:329-339.
25. Rigotti A, Trigatti B, Babitt J, Penman M, Xu S, Krieger M. Scavenger receptor BI: a cell surface receptor for high density lipoprotein. Curr Opin Lipidol. 1997;8:181-188.
26. Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RGW, Xu S, Krieger M. Murine SR-B1, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem. 1997;272:13242-13249.
27. Connelly MA, de la Llera-Moya M, Monzo P, Yancey PG, Drazul D, Stoudt G, Fournier N, Klein SM, Rothblat GH, Williams DL. Analysis of chimeric receptors shows that multiple functional activities of scavenger receptor, class B, type I (SRBI) are localized to the extracellular receptor domain. Biochemistry. 2001;40:5249-5259.
28. Rodrigueza WV, Thuahnai ST, Temel RE, Lund-Katz S, Phillips MC, Williams DL. Mechanism of scavenger receptor class B type I (SR-BI) mediated selective uptake of cholesteryl ester from high density lipoprotein to adrenal cells. J Biol Chem. 1999;274:20344-20350.
29. Rigotti A, Acton S, Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem. 1995;270:16221-16224.
30. Jian B, de la Llera-Moya M, Royer L, Rothblat G, Francone O, Swaney JB. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J Lipid Res. 1997;38:734-744.
31. 3H]cholesterol efflux to high density and low density lipoproteins is dependent on lipoprotein binding to the receptor. J Biol Chem. 2000;275:29993-30001.
32. Graf GA, Connell PM, van der Westhuyzen DR, Smart EJ. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae. J Biol Chem. 1999;274:12043-12048.
33. Liu T, Krieger M, Kan H-Y, Zannis VI. The effects of mutations in helices 4 and 6 of apoA-1 on scavenger receptor class B type I (SR-BI)mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoproteins and SR-BI is required for efficient lipid transport. J Biol Chem. 2002;277:21576-21584.
34. Hara H, Yokoyama S. Interaction of free apolipoproteins with macrophages. J Biol Chem. 1991;266:3080-3086.
35. Bielicki JK, Johnson WJ, Weinberg RB, Glick JM, Rothblat GH. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J Lipid Res. 1992;33:1699-1710.
36. Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, Segrest JP, Phillips MC, Rothblat GH. The efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 1995;34:7955-7965.
37. Francis GA, Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest. 1995;96:78-87.
38. Remaley AT, Schumacher UK, Stonik JA, Farsi BD, Nazih H, Brewer HB Jr. Decreased reverse cholesterol transport from Tangier disease fibroblasts: acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol. 1997;17:1813-1821.
39. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF. The Tangier disease gene product ABCI controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest. 1999;104:R25-R31.
40. Bodzioch M, Orsó E, Klucken T, Langmann T, Böttcher L, Diederich W, Drobnik W, Barlage S, Büchler C, Porsch-Özcürümez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999;22:347-351.
41. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denèfle P, Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 1999;22:352-355.
42. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, Van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HOF, Loubser O, Ouelette BFF, Fichter K, Ashbourne-Excoffon KJD, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJP. Mutations in ABCI in Tangier disease and familial highdensity lipoprotein deficiency. Nat Genet. 1999;22:336-345.
43. Assman G, von Eckardstein A, Brewer HB. Familial high density lipoprotein deficiency: Tangier disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill; 2002:2053-2072.
44. Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res. 2001;42:1007-1017.
45. Bungert S, Molday LL, Molday RS. Membrane topology of the ATP binding cassette transporter ABCR and its relationship to ABCI and related ABCA transporters. J Biol Chem. 2001;276:23539-23546.
46. 2terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space. J Biol Chem. 2001;276:15139-15145.
47. Fitzgerald ML, Morris AL, Rhee JS, Andersson LP, Mendez AJ, Freeman MW. Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem. 2002;277:33178-33187.
48. Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM. Comly M, Dwyer NK, Zhang M, Santamarina-Fojo S, Brewer HB Jr, Blanchette-Mackie EJ. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem. 2001;276:27584-27590.
49. Wang Y, Oram JF. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem. 2002;277:5692-5697.
50. Mendez AJ, Lin G, Wade DP, Lawn RM, Oram JF. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem. 2001;276:3158-3166.
51. 3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic. 2002;3:268-278.
52. a. Oram JF, HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol. 2003;23:720-727.
53. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by LXR/RXR. J Biol Chem. 2000;275:28240-28245.
54. Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL, Wright SD, Sparrow CP, Lund EG. 27-Hyroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem. 2001;276:38378-38387.
55. Schwartz K, Lawn RM, Wade DP. ABC1 gene expression and apoAI-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun. 2000;274:794-802.
56. Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J, Francone OL. The correlation of ABC1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem. 2000;275:28634-28640.
57. Arakawa R, Yokoyama S. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol Protease-mediated degradation. J Biol Chem. 2002;277:22426-22429.
58. Remaley AT, Stonik JA, Demosky SJ, Neufeld EB, Bocharov AV, Vishnyakova TG, Eggerman TL, Patterson AP, Duverger NJ, Santamarina-Fojo S, Brewer HB. Apolipoprotein specificity for lipid efflux by the human ABCA1 transporter. Biochem Biophys Res Commun. 2001;280:818-823.
59. Hara H, Komaba A, Yokoyama S,α-helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids. 1992;27:302-304.
60. Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest. 1994;94:1698-1705.
61. Gillotte KL, Zaiou M, Lund-Katz S, Anantharamaiah GM, Holvoet P, Dhoest A, Palgunachari MN, Segrest JP, Weisgraber KH, Rothblat GH, Phillips MC. Apolipoprotein-mediated plasma membrane microsolubilization: role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J Biol Chem. 1999;274:2021-2028.
62. Burgess JW, Frank PG, Franklin V, Liang P, McManus DC, Desforges M, Rassart E, Marcel YL. Deletion of C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage. Biochemistry. 1999;38:14524-14533.
63. Panagotopulos SE, Witting SR, Horace EM, Hui DY, Maiorano JN, Davidson WS. The role of apolipoprotein A-I helix 10 in apolipoproteinmediated cholesterol efflux via ATP-binding cassette transporter (ABCA1). J Biol Chem. 2002;277:39477-39484.
64. Sakr SW, Williams DL, Stoudt GW, Phillips MC, Rothblat GH. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. Biochim Biophys Acta. 1999;1438:85-98.
65. Oram JF, Lawn RM, Garvin MR, Wade DP. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem. 2000;275:34508-34511.
66. , Wang N, Silver D, Costet P, Tall AR. Specific binding of apoA-I enhanced cholesterol efflux and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem. 2000;275:33053-33058.
67. Chambenoit O, Hamon Y, Marguet D, Rigneault H, Rosseneu M, Chimini G. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J Biol Chem. 2001;276:9955-9960.
68. Lin GR, Oram JF. Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol. Atherosclerosis. 2000;149:359-370.
69. Fielding PE, Nagao K, Hakamata H, Chimini G, Fielding CJ. A two-step mechanism for free cholesterol, and phospholipid efflux from human vascular cells to apolipoprotein A-1. Biochem 2000;39:14113-14120.
70. Gillotte KL, Davidson WS, Lund-Katz S, Rothblat GH, Phillips MC. Removal of cellular cholesterol by pre-β-HDL involves plasma membrane microsolubilization. J Lipid Res. 1998;39:1918-1928.
71. Wang N, Silver DL, Thiele C, Tall AR. ATP-binding cassette transporter AI (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem. 2001;276:23742-23747.
72. Chen W, Sun Y, Welch C, Gorelik A, Leventhal AR, Tabas I, Tall AR. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. J Biol Chem. 2001;276:43564-43569.
73. Li Q, Tsujita M, Yokoyama S. Selective down-regulation of protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux to macrophages. Biochemistry. 1997;36:12045-12052.
74. Komaba A, Li Q, Hara H, Yokoyama S. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol. J Biol Chem. 1992;267:17560-17566.
75. Rothblat GH, de la Llera-Moya M, Favari E, Yancey PG, Kellner-Weibel G. Cellular cholesterol flux studies: methodological considerations. Atherosclerosis. 2002;163:1-8.
76. Kruth HS, Skarlatos SI, Gaynor PM, Gamble W. Production of cholesterol-rich nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. J Biol Chem. 1994;269:24511-24518.
77. Forte TM, Goth-Goldstein R, Nordhausen RW, McCall MR. Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J Lipid Res. 1993;34:317-324.
78. Gelissen IC, Rye K-A, Brown AJ, Dean RT, Jessup W. Oxysterol efflux from macrophage foam cells: the essential role of acceptor phospholipid. J Lipid Res. 1999;40:1636-1646.
79. Takahashi Y, Smith JD. Cholesterol efflux to apolipoprotein A1 involves endocytosis and resecretion in a calcium-dependent pathway. Proc Natl Acad Sci U S A. 1999;96:11358-11363.
80. Chao F-F, Amende LM, Blanchette-Mackie EJ, Skarlatos SI, Gamble W, Resau JH, Mergner WT, Kruth HS. Unesterified chotesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas. Am J Pathol. 1988;131:73-83.
81. Chen W, Silver DL, Smith JD, Tall AR. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages. J Biol Chem. 2000;275:30794-30800.
82. van Dam MJ, de Groot E, Clee SM, Hovingh GK, Brooks-Wilson A, Zwinderman AH, Smit AJ, Smelt AHM, Groen AK, Hayden MR, Kastelein JJP. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet. 2002;359:37-41.
83. Aiello RJ, Brees D, Bourassa P-A, Royer L, Lindsey S, Coskran T, Haghpassand M, Francone OL. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol. 2002;22:630-637.
84. Kozarsky KF, Donahee MH, Glick JM, Krieger M, Rader DJ. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol. 2000;20:721-727.
85. Huszar D, Varban ML, Rinninger F, Feeley R, Arai T, Fairchild-Huntress V, Donovan MJ, Tall AR. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol. 2000;20:1068-1073.